News related to the UNC Lineberger Comprehensive Cancer Center and the N.C. Cancer Hospital

Latest News from UNC Lineberger
NIH awards $11.6M grant to support study of retail tobacco policies across the U.S.
Three innovative and complementary research projects, done in partnership with UNC at Chapel Hill, Stanford University and Washington University in St. Louis, will examine the role of the tobacco retail environment in promoting tobacco use and causing tobacco-related illnesses.
Prostate cancer care for older men estimated to cost Medicare $1.2B
Researchers led by UNC Lineberger's Ronald C. Chen, MD, MPH, and Justin Trogdon, PhD, examined the costs associated with screening for prostate cancer, including treatment, for three years after diagnosis. They estimated that for men diagnosed in each of 2004, 2005, 2006, and 2007, the total cost for treating and screening for each group would be $1.2 billion for three years after diagnosis.
Findings could improve treatment for challenging acute leukemia in children
There is no consensus on the best way to treat mixed phenotype acute leukemia, a rare blood cancer with survival rates of between 47 and 75 percent for children. Researchers from St. Jude Children’s Research Hospital and the University of North Carolina Lineberger Comprehensive Cancer Center have made important discoveries about the genetics of this disease that could lead to better treatment.
Smith awarded $8.5M contract to compare treatments for recurrent bladder cancer
UNC Lineberger’s Angela B. Smith, MD, MS, an associate professor in the UNC School of Medicine Department of Urology and director of urologic oncology, and her collaborators were awarded a contract from the Patient-Centered Outcomes Research Institute to compare bladder removal with medical therapy in bladder cancer patients.
Johnson honored with Hyman L. Battle Distinguished Cancer Research Award
UNC Lineberger leaders held a reception Friday to honor Gary Johnson, PhD, the Kenan Distinguished Professor in the UNC School of Medicine Department of Pharmacology, and co-director of UNC Lineberger’s Molecular Therapeutics Program. During his 13-year tenure as chair, the Department if Pharmacology rose in national prominence and rankings. Johnson has been awarded the 2017-2018 Hyman L. Battle Distinguished Cancer Research Award.